Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
6 September 2005 | Volume 143 Issue 5 | Pages 355-361
This statement summarizes the U.S. Preventive Services Task Force (USPSTF) recommendations on genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility, along with the supporting scientific evidence. The complete information on which this statement is based, including evidence tables and references, is included in the evidence synthesis available through the USPSTF Web site (http://www.preventiveservices.ahrq.gov). The recommendation is also posted on the Web site of the National Guideline Clearinghouse (http://www.guideline.gov).
*For a list of the members of the U.S. Preventive Services Task Force, see the Appendix.
Author and Article Information
From the U.S. Preventive Services Task Force, Agency for Healthcare Research and Quality, Rockville, Maryland.
Individuals who wish to cite this recommendation statement should use the following format: U.S. Preventive Services Task Force. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility. Ann Intern Med. 2005;143:355-61.
Disclaimer: Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services.
Requests for Single Reprints: Reprints are available from the USPSTF Web site (http://www.preventiveservices.ahrq.gov) and in print through the Agency for Healthcare Research and Quality Publications Clearinghouse (800-358-9295). CLINICAL GUIDELINES
Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility: Recommendation Statement
![]()
Find additional patient-related information at:
Related articles in Annals:
This article has been cited by other articles:
![]() |
BRCA Screening Obstet. Gynecol., May 1, 2008; 111(5): 1205 - 1206. [Full Text] [PDF] |
||||
![]() |
M. Fatouros, G. Baltoyiannis, and D. H. Roukos The Predominant Role of Surgery in the Prevention and New Trends in the Surgical Treatment of Women With BRCA1/2 Mutations Ann. Surg. Oncol., January 1, 2008; 15(1): 21 - 33. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. O'Neill, N. T. Brewer, S. E. Lillie, E. F. Morrill, E. C. Dees, L. A. Carey, and B. K. Rimer Women's Interest in Gene Expression Analysis for Breast Cancer Recurrence Risk J. Clin. Oncol., October 10, 2007; 25(29): 4628 - 4634. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Burke and B. M. Psaty Personalized Medicine in the Era of Genomics JAMA, October 10, 2007; 298(14): 1682 - 1684. [Full Text] [PDF] |
||||
![]() |
M. Robson and K. Offit Management of an Inherited Predisposition to Breast Cancer N. Engl. J. Med., July 12, 2007; 357(2): 154 - 162. [Full Text] [PDF] |
||||
![]() |
J. N. Weitzel, V. I. Lagos, C. A. Cullinane, P. J. Gambol, J. O. Culver, K. R. Blazer, M. R. Palomares, K. J. Lowstuter, and D. J. MacDonald Limited Family Structure and BRCA Gene Mutation Status in Single Cases of Breast Cancer JAMA, June 20, 2007; 297(23): 2587 - 2595. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. F. Hayes Follow-up of Patients with Early Breast Cancer N. Engl. J. Med., June 14, 2007; 356(24): 2505 - 2513. [Full Text] [PDF] |
||||
![]() |
L. J. Spano A terrible beauty: A physician's story of ovarian cancer Can Fam Physician, June 1, 2007; 53(6): 983 - 985. [Full Text] [PDF] |
||||
![]() |
A. Qaseem, V. Snow, K. Sherif, M. Aronson, K. B. Weiss, D. K. Owens, and for the Clinical Efficacy Assessment Subcommittee Screening Mammography for Women 40 to 49 Years of Age: A Clinical Practice Guideline from the American College of Physicians Ann Intern Med, April 3, 2007; 146(7): 511 - 515. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Swisher and M.-C. King Defining Women at High Risk of Ovarian Cancer Cancer Res., March 15, 2007; 67(6): 2902 - 2902. [Full Text] [PDF] |
||||
![]() |
D. Saslow, C. Boetes, W. Burke, S. Harms, M. O. Leach, C. D. Lehman, E. Morris, E. Pisano, M. Schnall, S. Sener, et al. American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography CA Cancer J Clin, March 1, 2007; 57(2): 75 - 89. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Simard, M. Dumont, A.-M. Moisan, V. Gaborieau, H. Vezina, F. Durocher, J. Chiquette, M. Plante, D. Avard, P. Bessette, et al. Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer J. Med. Genet., February 1, 2007; 44(2): 107 - 121. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Acheson, S. J. Zyzanski, K. C. Stange, A. Deptowicz, and G. L. Wiesner Validation of a Self-Administered, Computerized Tool for Collecting and Displaying the Family History of Cancer J. Clin. Oncol., December 1, 2006; 24(34): 5395 - 5402. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Khatcheressian, A. C. Wolff, T. J. Smith, E. Grunfeld, H. B. Muss, V. G. Vogel, F. Halberg, M. R. Somerfield, and N. E. Davidson American Society of Clinical Oncology 2006 Update of the Breast Cancer Follow-Up and Management Guidelines in the Adjuvant Setting J. Clin. Oncol., November 1, 2006; 24(31): 5091 - 5097. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. V. Lacey Jr, M. H. Greene, S. S. Buys, D. Reding, T. L. Riley, C. D. Berg, R. M. Fagerstrom, and P. Hartge Ovarian Cancer Screening in Women With a Family History of Breast or Ovarian Cancer. Obstet. Gynecol., November 1, 2006; 108(5): 1176 - 1184. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Loud, N. E. Weissman, J. A. Peters, R. M. Giusti, B. S. Wilfond, W. Burke, and M. H. Greene Deliberate Deceit of Family Members: A Challenge to Providers of Clinical Genetics Services J. Clin. Oncol., April 1, 2006; 24(10): 1643 - 1646. [Full Text] [PDF] |
||||
![]() |
Correction: Summary for Patients: Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility Ann Intern Med, February 21, 2006; 144(4): 307 - 307. [Full Text] [PDF] |
||||
![]() |
K. E. Ormond, C. Bellcross, and S. Weissman Genetic risk assessment and BRCA mutation testing. Ann Intern Med, February 21, 2006; 144(4): 303 - 304. [Full Text] [PDF] |
||||
![]() |
J. L. Khatcheressian and T. J. Smith Randomized Trial of Long-Term Follow-Up for Early-Stage Breast Cancer: A Comparison of Family Physician Versus Specialist Care J. Clin. Oncol., February 20, 2006; 24(6): 835 - 837. [Full Text] [PDF] |
||||
![]() |
USPSTF: Recommendations for BRCA Testing Journal Watch Women's Health, November 22, 2005; 2005(1122): 6 - 6. [Full Text] |
||||
![]() |
USPSTF Recommends Against Routine BRCA Testing Journal Watch (General), September 27, 2005; 2005(927): 1 - 1. [Full Text] |
||||
![]() |
W. Burke Taking Family History Seriously Ann Intern Med, September 6, 2005; 143(5): 388 - 389. [Full Text] [PDF] |
||||
Read all Rapid Responses